Abstracts Archive - Page 2185 of 2607 - ACR Meeting Abstracts

Abstract Number: 730 • 2014 ACR/ARHP Annual Meeting
Prediction of Cardiac and Vascular Events in Systemic Sclerosis: Input from Endothelin-1 Type a Receptor Antibodies
Jerome Avouac¹, Gabriela Riemekasten², Christophe Meune³, Barbara Ruiz⁴ and Yannick Allanore¹, ¹Paris Descartes University, Rheumatology A Department and INSERM U1016, Cochin Hospital, Paris, France, ²Charité University Hospital and German Rheumatism Research Centre, a Leibniz Institute, Berlin, Germany, ³Paris 13 University, University Hospital of Paris-Seine-Saint-Denis, Cardiology Department, Bobigny, France, ⁴Paris Descartes University, INSERM U1016, Institut Cochin, Sorbonne Paris Cité, Paris, France
Background/Purpose: Cardiac and peripheral microvascular alterations are key features of systemic sclerosis (SSc). We have previously reported that angiogenic markers can predict the cardiovascular outcomes…
Abstract Number: 729 • 2014 ACR/ARHP Annual Meeting
A Dilated Esophagus Is an Independent Risk Factor for Interstitial Lung Disease in SSc
Carrie Richardson¹, Rishi Agrawal², Jungwha Lee³, Orit Almagor⁴, John Varga⁵, Rowland W. Chang⁶ and Monique E. Hinchcliff⁷, ¹Department of Medicine, McGaw Medical Center of Northwestern University, Chicago, IL, ²Department of Radiology, Northwestern University Feinberg School of Medicine, Chicago, IL, ³Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, ⁴Northwestern University, Chicago, IL, ⁵Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, ⁶Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, ⁷Northwestern University, Feinberg School of Medicine, Chicago, IL
Background/Purpose High-resolution computed tomography of the chest (HRCT) performed for assessment of interstitial lung disease (ILD) in patients with systemic sclerosis (SSc) frequently reveals a…
Abstract Number: 728 • 2014 ACR/ARHP Annual Meeting
Prediction and Impact of Attacks of Raynaud’s Phenomenon, As Judged By Patient perception
Michael Hughes¹, Amir Snapir², Jack Wilkinson³, Daniel Snapir², Fredrick M. Wigley⁴ and Ariane Herrick¹, ¹Centre for Musculoskeletal Research, The University of Manchester, Manchester, United Kingdom, ²Orion Corporation Orion Pharma, Turku, Finland, ³Research and Development, Salford Royal NHS Foundation Trust, Salford, United Kingdom, ⁴Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD
Background/Purpose Our aim was to evaluate (a) whether subjects with Raynaud's phenomenon (RP) can predict RP attacks because if so, then this could have implications…
Abstract Number: 727 • 2014 ACR/ARHP Annual Meeting
International Classification of Functioning, Disability, and Health (ICF) Core Sets for Connective Tissue Disease Interstitial Lung Disease (CTD-ILD) and Idiopathic Pulmonary Fibrosis (IPF) – a Necessary Map to Health Care Provision in the Era of ICD-11
Reuben Escorpizo^1,2, Kevin J. Keen³, Kim Fligelstone⁴, Matthew R. Lammi⁵, Daphne LeSage⁶, Anne-Marie Russell⁷, Surinder Birring⁸, Catherine Sarver⁹, Janos Varga¹⁰, Oliver Distler¹¹ and Lesley Ann Saketkoo¹², ¹ICF Research Branch in cooperation with the WHO Collaborating Centre for the Family of International Classifications in Germany (DIMDI), Nottwil, Switzerland, ²Department of Physical Therapy, 2Louisiana State University Health Sciences Center, New Orleans, LA, ³University of Northern British Columbia, Health Research Institute, Prince George, BC, Canada, ⁴Royal Free Hospital, Scleroderma Unit and Scleroderma Society, London, United Kingdom, ⁵Louisiana State University Health Sciences Center, Pulmonary and Critical Medicine, New Orleans, LA, ⁶Center for CCH at State of Louisiana, New Orleans, LA, ⁷National Heart Lung Institute, Royal Brompton Hospital,, London, United Kingdom, ⁸King's College Hospital NHS Foundation Trust, London, United Kingdom, ⁹Johns Hopkins, Baltimore, MD, ¹⁰National Koranyi Institute for TB and Pulmonology, Budapest, Hungary, ¹¹Division of Rheumatology, University Hospital Zurich, Zurich, Switzerland, ¹²Scleroderma and Sarcoidosis Patient Care and Research Center, Rheumatology and Pulmonary Medicine, Louisiana State University Health Sciences Center, New Orleans, LA
Background/Purpose: A recent consensus project (Saketkoo et al, Thorax 2014) recommended a minimum core set of outcome measures for use in future clinical trials of…
Abstract Number: 726 • 2014 ACR/ARHP Annual Meeting
Risk of Ischemic Stroke in Patients with Systemic Sclerosis: A Systematic Review and Meta-Analysis
Patompong Ungprasert¹, Praveen Ratanasrimetha², Charat Thongprayoon³, Wisit Cheungpasitporn³ and Promporn Suksaranjit⁴, ¹Department of Internal medicine, Bassett medical center, Cooperstown, NY, ²Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, ³Department of Medicine, Mayo clinic, Rochester, MN, ⁴Department of Cardiology, University of Utah School of Medicine, Salt Lake City, UT
Risk of Ischemic Stroke in Patients with Systemic Sclerosis: A Systematic Review and Meta-analysisBackground/Purpose: Several chronic inflammatory disorders, such as rheumatoid arthritis and systemic lupus…
Abstract Number: 725 • 2014 ACR/ARHP Annual Meeting
Reduced Diffusing Capacity of Carbon Monoxide Is Independently Associated with Worse Subclinical Left Ventricular Function on Speckle-Tracking Echocardiography in Systemic Sclerosis
Monique Hinchcliff¹, Vistasp Daruwalla², Lauren Beussink-Nelson³, Sofia Podlusky⁴, Mary A. Carns⁴, John Varga⁵, Michael Cuttica⁶ and Sanjiv J. Shah⁷, ¹Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, ²Department of Internal Medicine, Division of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, IL, ³Department of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, IL, ⁴Department of Medicine, Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, ⁵Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, ⁶Department of Medicine, Division of Pulmonary and Critical Care Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, ⁷Cardiology, Northwestern University Feinberg School of Medicine, Chicago, IL
Background/Purpose: Reduced diffusing capacity of carbon monoxide (DLCO) is a predictor of worse outcomes in patients with systemic sclerosis (SSc). Traditionally, the association between low…
Abstract Number: 724 • 2014 ACR/ARHP Annual Meeting
Moderate Decline in Forced Vital Capacity is Associated with a Poor Outcome in Systemic Sclerosis Patients
Anna-Maria Hoffmann-Vold¹, Oyvind Midtvedt², Torhild Garen³, May Brit Lund⁴, T. Mogens Aalokken⁵, Jan Tore Gran² and Oyvind Molberg⁶, ¹Department of Rheumatology, Department of Rheumatology, Oslo University Hospital Rikshospitalet, Oslo, Norway, ²Rheumatology, Oslo University Hospital, Oslo, Norway, ³Department of Rheumatology, Oslo University Hospital Rikshospitalet, Oslo, Norway, ⁴Department of Respiratory Medicine, Oslo University Hospital Rikshopitalet, Oslo, Norway, ⁵Department of Radiology, Oslo University Hospital Rikshospitalet, Oslo, Norway, ⁶Department of Rheumatology, Oslo University Hospital, Rikshospitalet, Oslo, Norway
Background/Purpose: Interstitial lung disease (ILD) is a common manifestation in systemic sclerosis (SSc) and the leading cause of morbidity and mortality. Serial pulmonary function tests…
Abstract Number: 723 • 2014 ACR/ARHP Annual Meeting
Early Mortality in Australian, Canadian and Spanish Scleroderma Patients: Rationale for Establishing a Multi-National Inception Cohort of Patients with Systemic Sclerosis
YanJie Hao¹, Marie Hudson^2,3, Patricia Carreira⁴, Wendy Stevens^1,5, Candice Rabusa⁶, Solene Tatibouet^7,8, Loreto Carmona⁹, Beatriz E Joven¹⁰, Susanna Proudman^11,12, Murray Baron^7,8 and Mandana Nikpour^1,13, ¹Rheumatology, St. Vincent’s Hospital Melbourne, Melbourne, Australia, ²Rheumatology, Lady David Institute for Medical Research and Jewish General Hospital, Montreal, QC, Canada, ³Division of Rheumatology, McGill University, Montreal, QC, Canada, ⁴Rheumatology, Hospital Universitario 12 de Octubre, Madrid, Spain, ⁵The University of Melbourne Department of Medicine at St. Vincent’s Hospital Melbourne, Melbourne, Australia, ⁶Rheumatology, The University of Melbourne at St Vincent’s Hospital, Melbourne, Australia, ⁷Rheumatology, Jewish General Hospital, Montreal, QC, Canada, ⁸Rheumatology, Lady David Research Institute, Montreal, QC, Canada, ⁹Instituto de Salud Musculoesqueletica, Madrid, Spain, ¹⁰Rheumatology, Hospital Universitario, Madrid, Spain, ¹¹Rheumatology Unit, Royal Adelaide Hospital, Adelaide, Australia, ¹²Discipline of Medicine, University of Adelaide, Adelaide, Australia, ¹³Medicine, The University of Melbourne at St. Vincent’s Hospital, Melbourne, Australia
Background/Purpose Studies of ‘prevalent' cohorts wherein most patients have longstanding disease at recruitment may underestimate mortality in systemic sclerosis (SSc) due to survivor bias. The…
Abstract Number: 722 • 2014 ACR/ARHP Annual Meeting
Prediction of Improvement in Skin Fibrosis in Diffuse Cutaneous Systemic Sclerosis
Rucsandra Dobrota^1,2, Britta Maurer¹, Nicole Graf³, Carina Mihai², Otylia Kowal-Bielecka⁴, Yannick Allanore⁵ and Oliver Distler on behalf of the EUSTAR investigators and co-authors¹, ¹Division of Rheumatology, University Hospital Zurich, Zurich, Switzerland, ²Department of Internal Medicine and Rheumatology, Dr.I.Cantacuzino Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania, ³graf biostatistics, Winterthur, Switzerland, ⁴Department of Rheumatology and Internal Medicine, Medical University of Bialystok, Bialystok, Poland, ⁵Department of Rheumatology, University Paris Descartes and Cochin Hospital, Paris, France
Background/Purpose Improvement of skin fibrosis over time is part of the “natural history” of patients with diffuse cutaneous systemic sclerosis (dcSSc). However, in the individual…
Abstract Number: 706 • 2014 ACR/ARHP Annual Meeting
Humoral Immunodeficiency in Patients Presenting with Clinical Features of Systemic Lupus Erythematosus
W. Winn Chatham¹, Duncan Harmon² and Harry W. Schroeder Jr.³, ¹University of Alabama at Birmingham, Birmingham, AL, ²Medicine/Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ³Medicine, University of Alabama-Birmingham, Birmingham, AL
Background/Purpose: Humoral immunodeficiency syndromes including common variable immune deficiency (CVID) are not uncommonly associated with autoimmunity. The spectrum of autoimmune disorders encountered in CVID patients…
Abstract Number: 705 • 2014 ACR/ARHP Annual Meeting
Lupus Chest Pain in the Emergency Department: a Common Diagnostic Dilemma
Masoom Modi¹, Mariko L. Ishimori¹, Daniel J. Wallace² and Michael Weisman¹, ¹Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, ²Rheumatology, Cedars-Sinai/David Geffen School of Medicine at UCLA, Los Angeles, CA
Background/Purpose: Chest pain (CP) is a common symptom reported by SLE patients often leading to presentation to Emergency Departments (ED). The origin of CP…
Abstract Number: 704 • 2014 ACR/ARHP Annual Meeting
Utility and Associated Risk of Pulmonary Embolism CT Scans in the Michigan Lupus Cohort
Ruba Kado¹, Emily Siegwald², Emily Lewis², Mitch Goodsitt³, Emmanuel Christodoulou³, Ella Kazerooni³ and W. Joseph McCune⁴, ¹Internal Medicine-Rheumatology, University of Michigan, Ann Arbor, MI, ²Rheumatology, University of Michigan, Ann Arbor, MI, ³Radiology, University of Michigan, Ann Arbor, MI, ⁴Internal Medicine/Rheumatology, University of Michigan, Ann Arbor, MI
Background/Purpose: Ionizing radiation from CT scanning can increase cancer risk. Lupus patients are frequently evaluated for chest pain and may have multiple pulmonary embolism CT…
Abstract Number: 703 • 2014 ACR/ARHP Annual Meeting
Autoimmune Hepatitis in Systemic Lupus Erythematosus
Doo-Ho Lim, Seung-Hyeon Bae, Soo Min Ahn, Seokchan Hong, Yong-Gil Kim, Chang-Keun Lee and Bin Yoo, Division of Rheumatology, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea
Background/Purpose: Autoimmune Hepatitis (AIH) is a chronic progressive liver disease of unknown cause, characterized by circulating autoantibodies and hyperglobulinemia. Patients with AIH often have other…
Abstract Number: 702 • 2014 ACR/ARHP Annual Meeting
Protein Losing Enteropathy in Systemic Lupus Erythematosus
Doo-Ho Lim, Seung-Hyn Bae, Soo Min Ahn, Seokchan Hong, Yong-Gil Kim, Chang-Keun Lee and Bin Yoo, Division of Rheumatology, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea
Background/Purpose: Protein losing enteropathy (PLE), characterized by severe hypoalbuminemia and edema, is rare manifestation of systemic lupus erythematosus (SLE). The study was proposed to identify…
Abstract Number: 701 • 2014 ACR/ARHP Annual Meeting
How Important Is Physical Activity for Patients with Systemic Lupus Erythematodes? -Results of Lula-Study
Isabelle Kloubert¹, Gamal Chehab¹, Jutta Richter², Rebecca Fischer-Betz³, Ralph Brinks² and Matthias Schneider¹, ¹Department of Rheumatology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany, ²Rheumatology, Heinrich-Heine-University, Düsseldorf, Germany, ³Department of Rheumatology, University of Düsseldorf, Düsseldorf, Germany
Background/Purpose Physical activity (PA) plays a decisive role in primary and secondary prevention in various domains of medicine. Our examination aimed to determine association PA…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].